Physician profile
Patrick A Scott
NPI 1639463474
$886.78
in general payments reported to CMS, 2019-2025
9 companies · $696 in 2025
The $696 reported for 2025 was more than what 85% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24.03 · 2020: $52.63 · 2021: $20.24 · 2022: $13.65 · 2024: $80.50 · 2025: $696.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $444 · Travel and Lodging: $332.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $444.11 |
| Travel and Lodging | $332.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec USA, INC. | $490.97 | 2025 | Cirrus Hd-Oct |
| Bausch & Lomb Americas INC. | $205.22 | 2024-2025 | Infuse |
| Lombart Brothers, INC. | $52.63 | 2020 | |
| Mallinckrodt Hospital Products INC. | $36.38 | 2024 | Acthar |
| Rxsight INC | $25.83 | 2024 | Rxsight Injector Cartridge, Light Adjustable Lens (Lal), Rxsight Contact Lens |
| Novartis Pharmaceuticals Corporation | $24.03 | 2019 | |
| Allergan, INC. | $20.24 | 2021 | |
| Amgen INC. | $17.83 | 2025 | Tepezza |
| Johnson & Johnson Vision Care, INC. | $13.65 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Scott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.